On 6 February 2023, one of the most important events in the IVD sector in the world starts in Dubai. MEDLAB Middle East has the purpose of sharing knowledge and the latest technology in the medical laboratory and in vitro diagnostics market.Hangzhou Clongene Biotech joinsthe...

The TGA is reviewing all COVID-19-specific laboratory antigen tests and rapid antigen tests (RATs), including point-of-care and self-tests, included in the Australian Register of Therapeutic Goods (ARTG). The purpose of the review is to determine if tests have been impacted ...

July 28, 2022, AACC ended successfully in Chicago which can function like a lens to focus our attention on emerging science and clinical developments that are of contemporary importance.Clongene brought main products, such as infectious diseases, drugs of abuse, COVID-19 Ant...

In February 2022, CLUNGENE®COVID-19 Antigen Rapid Test for self-testing manufactured by Clongene has obtained the CE certification in EU. Our self-testing product can be sold in the European Union and other countries that recognize the CE certification.CLUNGENE®COVID-19 Anti...

“Clungene COVID-19 Antigen Rapid Test for self-testing” and “Clungene COVID-19 Antigen Rapid Test” manufactured by Clongene have obtained the TGA Certification in Australia on January 7, 2022. The certifications indicate that the Clungene COVID-19 Antigen Rapid Test products...